Biocon Biologics  /  Stories

STORIES

Brand Stories

Biocon Biologics has demonstrated success and established global credibility with several of its molecules being approved and launched in both developed and emerging markets. The company is at an important inflection point as it gains commercial success with its first wave of products and invests in long term sustainability through broadening of its pipeline and commercial presence, further expanding manufacturing scale, and two strategic transactions with Serum Institute Life Sciences and Viatris.

You can read about how Biocon Biologics is evolving as a brand as it focuses, invests, competes and wins in the large and growing opportunity from biosimilars worldwide.

Other Stories

Biocon Biologics has a comprehensive plan to integrate Viatris business

Biocon Biologics has put together a comprehensive plan to integrate the acquired Viatris business to ensure continuity of supply and relations with all customers.

More >>

Poised for Global Leadership
Leveraging ‘The Power of One’; Enabling Affordable Access to Lifesaving Biosimilars, Worldwide.

More >> 

Strategic Alliance with Serum Institute to Impact Global Health

Strategic Alliance with Serum Institute to Impact Global Health
Positioned for Value Creation Through Vaccines

More >> 

She Inspires

She Inspires

The inspiring tales of our own Women In Science at Biocon Biologics.

More >>

Hope. Now within reach.
Aiming to reach a billion patients worldwide with affordable, lifesaving medicines.

More >> 

Addressing the COVID-19 Pandemic
The Biocon Group addressed the COVID-19 pandemic unitedly with undeterred spirit and unwavering purpose.

More >>

Meeting unmet patient needs Our novel biologics address unmet medical needs across the world.

More >>

Research saves lives We are accelerating drug innovation and development for companies globally.

More >>

The 10-cent answer to diabetes At 10 cents a day, our insulin is a game changer in the developing world.

More >>

EMPLOYEE Stories

Ankur Bhatnagar, our General Manager for Science and Technology Innovation, talks about how he and his team overcome challenges in designing production processes.

More >>

Sivanandam K, Our Global Program Head – Program Management, highlights how Program Management has evolved since its inception in 2009.

More >>

Deepa Mohan, Our Senior Scientific Manager – R&D, highlights how the Biocon culture is primarily based on innovation.

More >>

Anita Rao, Our Project Group Lead – R&D, talks about how her experience in Biocon has enriched her both professionally and technically.

More >>

Patient Stories

Pooja Hurkat’s struggle with TYPE 1 diabetes

More >> 

Meet Kumudha Raju, one of the many women fighting HER2-Positive breast cancer

More >>

Neelam’s fight against ascites and ovarian cancer

More >>

Share